13F HOLDINGS REPORT
SECTOR GAMMA AS
Quarter ended Q4 2023 · Filed November 6, 2023 · Accession 0000945621-23-000545
Total Value
$391.3M
Positions
28
Other Managers
0
Confidential Omitted
No
Holdings (28)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | GILEAD SCIENCES INC | GILD | 623,123 | $46.7M | 11.93% |
| 2 | BRISTOL-MYERS SQUIBB CO | CELG-RI | 671,780 | $39.0M | 9.96% |
| 3 | BIOGEN INC | BIIB | 104,286 | $26.8M | 6.85% |
| 4 | MEDTRONIC PLC | MDT | 327,903 | $25.7M | 6.57% |
| 5 | INCYTE CORP | INCY | 432,545 | $25.0M | 6.39% |
| 6 | CARDINAL HEALTH INC | CAH | 264,136 | $22.9M | 5.86% |
| 7 | BECTON DICKINSON & CO | BDX | 71,884 | $18.6M | 4.75% |
| 8 | ELEVANCE HEALTH INC | ELV | 41,147 | $17.9M | 4.58% |
| 9 | ZIMMER BIOMET HOLDINGS INC | ZBH | 159,069 | $17.9M | 4.56% |
| 10 | GE HEALTHCARE TECHNOLOGIES I | GEHC | 229,589 | $15.6M | 3.99% |
| 11 | CENTENE CORP DEL | CNC | 223,148 | $15.4M | 3.93% |
| 12 | EDWARDS LIFESCIENCES CORP | EW | 212,995 | $14.8M | 3.77% |
| 13 | LABORATORY CORP AMER HLDGS | 50540R409 | 64,857 | $13.0M | 3.33% |
| 14 | GLOBUS MED INC | GMED | 221,827 | $11.0M | 2.81% |
| 15 | TENET HEALTHCARE CORP | THC | 157,975 | $10.4M | 2.66% |
| 16 | CATALENT INC | 148806102 | 207,129 | $9.4M | 2.41% |
| 17 | ALNYLAM PHARMACEUTICALS INC | ALNY | 52,968 | $9.4M | 2.40% |
| 18 | BIOMARIN PHARMACEUTICAL INC | BMRN | 96,048 | $8.5M | 2.17% |
| 19 | IONIS PHARMACEUTICALS INC | IONS | 165,616 | $7.5M | 1.92% |
| 20 | BAXTER INTL INC | 071813109 | 193,243 | $7.3M | 1.86% |
| 21 | BRUKER CORP | BRKRP | 103,355 | $6.4M | 1.65% |
| 22 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 115,166 | $4.1M | 1.05% |
| 23 | QIAGEN NV | QGEN | 100,713 | $4.1M | 1.04% |
| 24 | ACADIA PHARMACEUTICALS INC | ACAD | 179,785 | $3.7M | 0.96% |
| 25 | LANTHEUS HLDGS INC | LNTH | 50,962 | $3.5M | 0.90% |
| 26 | KENVUE INC | KVUE | 144,017 | $2.9M | 0.74% |
| 27 | AMEDISYS INC | 023436108 | 24,585 | $2.3M | 0.59% |
| 28 | VIR BIOTECHNOLOGY INC | VIR | 148,538 | $1.4M | 0.36% |